JIANG Yin, YIN Cha. Analysis of rational use of Chinese patent medicine in a hospital outpatient pharmacy in Shanghai from 2015 to 2017[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(4): 380-384. doi: 10.3969/j.issn.1006-0111.2019.04.019
| Citation:
|
JIANG Yin, YIN Cha. Analysis of rational use of Chinese patent medicine in a hospital outpatient pharmacy in Shanghai from 2015 to 2017[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(4): 380-384. doi: 10.3969/j.issn.1006-0111.2019.04.019
|
Analysis of rational use of Chinese patent medicine in a hospital outpatient pharmacy in Shanghai from 2015 to 2017
- 1.
Editorial Department of Journal of Second Military Medical University, Naval Medical University, Shanghai 200433, China;Pharmaceutical Department, Dahua Hospital, Shanghai 200237, China
- 2.
Editorial Department of Journal of Second Military Medical University, Naval Medical University, Shanghai 200433, China
- Received Date: 2018-10-07
- Rev Recd Date:
2018-12-27
-
Abstract
Objective To analyze the utilization of Chinese patent medicines in a hospital outpatient pharmacy in Shanghai and evaluate the effectiveness of measures to control the component ratio of the medications. Methods The sales volume and total cost of outpatient Chinese patent medicines in the hospital from January 1,2015 to December 31,2017 were investigated.The medication usage was analyzed by DDDs and DUI. Results With only 8.4% drop in the outpatient numbers,the total cost of Chinese patent medicine in the outpatient pharmacy decreased from 14.968 million yuan in 2015 to 11.475 million yuan in 2017,a decrease of 23.3%.The number of Chinese patent medicines used in the hospital decreased sharply from 362414.6 boxes/bottles in 2015 to 270144.5 boxes/bottles in 2017,a decrease of 25.5%.DDDs of most drugs showed a steady downward trend,but the DUI index did not change significantly. Conclusion The hospital has taken effective measures to reduce the component ratio and cost of medications to promote rational drug use since 2016. The phased target of reducing the component ratio of medications to 35% in 2017 was achieved. The use of Chinese patent medicines tends to be reasonable.
-
References
|
[1]
|
国务院关于印发"十三五"深化医药卫生体制改革规划的通知[EB/OL].(2017-01-09)[2018-05-04].http://www.gov.cn/zhengce/content/2017-01/09/content_5158053.htm. |
|
[2]
|
上海市人民政府关于印发《上海市深化医药卫生体制综合改革试点方案(2016-2020年)》的通知[EB/OL].(2016-05-25)[2018-05-04].http://www.shanghai.gov.cn/nw2/nw2314/nw2319/nw10800/nw39220/nw39369/u26aw48346.html. |
|
[3]
|
刘萍,刘敏超,何新荣,等.我院中成药用药现状调查及经济学分析[J].中国药房,2008,19(12):940-942. |
|
[4]
|
国家药典委员会.中华人民共和国药典临床用药须知:中药成方制剂卷[M].北京:中国医药科技出版社,2011:187. |
|
[5]
|
陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:808. |
|
[6]
|
王涛,刘静,杨华,等.CDR用药手册(2008年版)[M].香港:中国国际出版社,2008:746. |
|
[7]
|
傅喆暾,瞿江媛,陈红君,等.2009-2011年上海市杨浦区中心医院中成药应用分析[J].中国医院用药评价与分析,2013,13(3):210-213. |
|
[8]
|
尤永真,戴文元.2010年门诊中成药应用分析[J].海峡药学,2012,24(6):248-250. |
|
[9]
|
孙家艳,顾云霞.2009-2011年我院中成药用药分析[J].中国医院用药评价与分析,2013,13(6):511-514. |
|
[10]
|
柴海霞.我院2008年至2010年中成药使用分析[J].中国药业,2012,21(13):53-54. |
|
[11]
|
尹畅,张超黎,赵颖波,等.我国143家三级甲等医院头孢菌素类抗菌药物使用分析.中国医疗管理科学,2018,3(8):5-10. |
|
[12]
|
慕燕萍.莫西沙星治疗泌尿生殖系感染临床意义的研究[D].广州:南方医科大学,2012. |
|
[13]
|
董伟,王颖,汤善健,等.医院追求高价药巍然成风,降价药品百姓难以见面:以2000-2008年上海市医疗机构青霉素使用为例[J].中国卫生资源,2010,13(4):158-161. |
|
[14]
|
陈太权,蔡惠惠.医院中成药使用情况分析[J].中国当代医药,2009, 16(21):121-122. |
|
[15]
|
金萍妹.某三级甲等肿瘤医院药品零差率实施效果分析[J].中国医院管理,2017,37(6):14-16. |
|
[16]
|
唐勇.我院近3年口服中成药使用情况分析[J].贵阳中医学院学报,2015,37(6):83-85. |
-
-
Proportional views
-
DownLoad: